Salvinorina A (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Salvinorina A" in Spanish language version.

refsWebsite

Global rank Spanish rank

21doi.org

2^nd place

21nih.gov

4^th place

2jstor.org

26^th place

56^th place

1harvard.edu

18^th place

34^th place

1proquest.com

206^th place

1,369^th place

1sciencephoto.com

low place

doi.org

dx.doi.org

Butelman ER, Kreek MJ (2015). «Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders». Frontiers in Pharmacology 6: 190. PMC 4561799. PMID 26441647. doi:10.3389/fphar.2015.00190.
MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR (March 2013). «Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects». Psychopharmacology 226 (2): 381-392. PMC 3581702. PMID 23135605. doi:10.1007/s00213-012-2912-9.
Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (September 2002). «Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist». Proceedings of the National Academy of Sciences of the United States of America 99 (18): 11934-11939. Bibcode:2002PNAS...9911934R. JSTOR 3073142. PMC 129372. PMID 12192085. doi:10.1073/pnas.182234399.
Ortega A, Blount JF, Manchard PD (1982). «Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum (Labiatae)». Journal of the Chemical Society, Perkin Transactions 1: 2505-8. doi:10.1039/P19820002505.
Valdés III LJ, Butler WM, Hatfield GM, Paul AG, Koreeda M (1984). «Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint Salvia divinorum». Journal of Organic Chemistry 49 (24): 4716-20. doi:10.1021/jo00198a026.
Valdés LJ, Chang HM, Visger DC, Koreeda M (November 2001). «Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum». Organic Letters 3 (24): 3935-3937. PMID 11720573. doi:10.1021/ol016820d.
Prisinzano TE (December 2005). «Psychopharmacology of the hallucinogenic sage Salvia divinorum». Life Sciences 78 (5): 527-531. PMID 16213533. doi:10.1016/j.lfs.2005.09.008.
Harding WW, Schmidt M, Tidgewell K, Kannan P, Holden KG, Gilmour B, Navarro H, Rothman RB, Prisinzano TE (January 2006). «Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A». Journal of Natural Products 69 (1): 107-112. PMC 2544632. PMID 16441078. doi:10.1021/np050398i.
Johnson MW, MacLean KA, Caspers MJ, Prisinzano TE, Griffiths RR (April 2016). «Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans». Journal of Psychopharmacology 30 (4): 323-329. PMC 5289219. PMID 26880225. doi:10.1177/0269881116629125.
Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, Sitte HH, Ramamoorthy S, Shippenberg TS (November 2014). «Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism». Neuropharmacology 86: 228-240. PMC 4188751. PMID 25107591. doi:10.1016/j.neuropharm.2014.07.016.
Siebert DJ (June 1994). «Salvia divinorum and salvinorin A: new pharmacologic findings». Journal of Ethnopharmacology 43 (1): 53-56. PMID 7526076. doi:10.1016/0378-8741(94)90116-3.
Placzek MS, Van de Bittner GC, Wey HY, Lukas SE, Hooker JM (December 2015). «Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET». Neuropsychopharmacology 40 (13): 2865-2872. PMC 4864638. PMID 26058662. doi:10.1038/npp.2015.159.
Kutrzeba L, Dayan FE, Howell J, Feng J, Giner JL, Zjawiony JK (July 2007). «Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway». Phytochemistry 68 (14): 1872-1881. PMC 2065853. PMID 17574635. doi:10.1016/j.phytochem.2007.04.034.
Pelot KA, Mitchell R, Kwon M, Hagelthorn LM, Wardman JF, Chiang A, Bohlmann J, Ro DK, Zerbe P (March 2017). «Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase». The Plant Journal 89 (5): 885-897. PMID 27865008. doi:10.1111/tpj.13427.
Siebert DJ (June 2004). «Localization of salvinorin A and related compounds in glandular trichomes of the psychoactive sage, Salvia divinorum». Annals of Botany 93 (6): 763-771. JSTOR 43576030. PMC 4242294. PMID 15087301. doi:10.1093/aob/mch089.
Scheerer JR, Lawrence JF, Wang GC, Evans DA (July 2007). «Asymmetric synthesis of salvinorin A, a potent kappa opioid receptor agonist». Journal of the American Chemical Society 129 (29): 8968-8969. PMID 17602636. doi:10.1021/ja073590a.
Nozawa M, Suka Y, Hoshi T, Suzuki T, Hagiwara H (April 2008). «Total synthesis of the hallucinogenic neoclerodane diterpenoid salvinorin A». Organic Letters 10 (7): 1365-1368. PMID 18311991. doi:10.1021/ol800101v.
Burns AC, Forsyth CJ (January 2008). «Intramolecular Diels-Alder/Tsuji allylation assembly of the functionalized trans-decalin of salvinorin A». Organic Letters 10 (1): 97-100. PMID 18062692. doi:10.1021/ol7024058.
Line NJ, Burns AC, Butler SC, Casbohm J, Forsyth CJ (December 2016). «Total Synthesis of (-)-Salvinorin A». Chemistry 22 (50): 17983-17986. PMID 27758012. doi:10.1002/chem.201604853.
Brito-da-Costa AM, Dias-da-Silva D, Gomes NG, Dinis-Oliveira RJ, Madureira-Carvalho Á (February 2021). «Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects». Pharmaceuticals 14 (2): 116. PMC 7913753. PMID 33546518. doi:10.3390/ph14020116.
Hatipoglu SD, Yalcinkaya B, Akgoz M, Ozturk T, Goren AC, Topcu G (November 2017). «Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species». Phytochemical Analysis 28 (6): 541-549. PMID 28722248. doi:10.1002/pca.2703.

harvard.edu

adsabs.harvard.edu

Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (September 2002). «Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist». Proceedings of the National Academy of Sciences of the United States of America 99 (18): 11934-11939. Bibcode:2002PNAS...9911934R. JSTOR 3073142. PMC 129372. PMID 12192085. doi:10.1073/pnas.182234399.

jstor.org

Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (September 2002). «Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist». Proceedings of the National Academy of Sciences of the United States of America 99 (18): 11934-11939. Bibcode:2002PNAS...9911934R. JSTOR 3073142. PMC 129372. PMID 12192085. doi:10.1073/pnas.182234399.
Siebert DJ (June 2004). «Localization of salvinorin A and related compounds in glandular trichomes of the psychoactive sage, Salvia divinorum». Annals of Botany 93 (6): 763-771. JSTOR 43576030. PMC 4242294. PMID 15087301. doi:10.1093/aob/mch089.

nih.gov

ncbi.nlm.nih.gov

Butelman ER, Kreek MJ (2015). «Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders». Frontiers in Pharmacology 6: 190. PMC 4561799. PMID 26441647. doi:10.3389/fphar.2015.00190.
MacLean KA, Johnson MW, Reissig CJ, Prisinzano TE, Griffiths RR (March 2013). «Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects». Psychopharmacology 226 (2): 381-392. PMC 3581702. PMID 23135605. doi:10.1007/s00213-012-2912-9.
Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (September 2002). «Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist». Proceedings of the National Academy of Sciences of the United States of America 99 (18): 11934-11939. Bibcode:2002PNAS...9911934R. JSTOR 3073142. PMC 129372. PMID 12192085. doi:10.1073/pnas.182234399.
Valdés LJ, Chang HM, Visger DC, Koreeda M (November 2001). «Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum». Organic Letters 3 (24): 3935-3937. PMID 11720573. doi:10.1021/ol016820d.
Prisinzano TE (December 2005). «Psychopharmacology of the hallucinogenic sage Salvia divinorum». Life Sciences 78 (5): 527-531. PMID 16213533. doi:10.1016/j.lfs.2005.09.008.
Harding WW, Schmidt M, Tidgewell K, Kannan P, Holden KG, Gilmour B, Navarro H, Rothman RB, Prisinzano TE (January 2006). «Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A». Journal of Natural Products 69 (1): 107-112. PMC 2544632. PMID 16441078. doi:10.1021/np050398i.
Johnson MW, MacLean KA, Caspers MJ, Prisinzano TE, Griffiths RR (April 2016). «Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans». Journal of Psychopharmacology 30 (4): 323-329. PMC 5289219. PMID 26880225. doi:10.1177/0269881116629125.
Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, Sitte HH, Ramamoorthy S, Shippenberg TS (November 2014). «Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism». Neuropharmacology 86: 228-240. PMC 4188751. PMID 25107591. doi:10.1016/j.neuropharm.2014.07.016.
Siebert DJ (June 1994). «Salvia divinorum and salvinorin A: new pharmacologic findings». Journal of Ethnopharmacology 43 (1): 53-56. PMID 7526076. doi:10.1016/0378-8741(94)90116-3.
Placzek MS, Van de Bittner GC, Wey HY, Lukas SE, Hooker JM (December 2015). «Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET». Neuropsychopharmacology 40 (13): 2865-2872. PMC 4864638. PMID 26058662. doi:10.1038/npp.2015.159.
Kutrzeba L, Dayan FE, Howell J, Feng J, Giner JL, Zjawiony JK (July 2007). «Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway». Phytochemistry 68 (14): 1872-1881. PMC 2065853. PMID 17574635. doi:10.1016/j.phytochem.2007.04.034.
«Salvia divinorum kolavenyl diphosphate synthase (CPS2) mRNA, complete cds». 11 de diciembre de 2016 – via NCBI Nucleotide.
Pelot KA, Mitchell R, Kwon M, Hagelthorn LM, Wardman JF, Chiang A, Bohlmann J, Ro DK, Zerbe P (March 2017). «Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase». The Plant Journal 89 (5): 885-897. PMID 27865008. doi:10.1111/tpj.13427.
Siebert DJ (June 2004). «Localization of salvinorin A and related compounds in glandular trichomes of the psychoactive sage, Salvia divinorum». Annals of Botany 93 (6): 763-771. JSTOR 43576030. PMC 4242294. PMID 15087301. doi:10.1093/aob/mch089.
Scheerer JR, Lawrence JF, Wang GC, Evans DA (July 2007). «Asymmetric synthesis of salvinorin A, a potent kappa opioid receptor agonist». Journal of the American Chemical Society 129 (29): 8968-8969. PMID 17602636. doi:10.1021/ja073590a.
Nozawa M, Suka Y, Hoshi T, Suzuki T, Hagiwara H (April 2008). «Total synthesis of the hallucinogenic neoclerodane diterpenoid salvinorin A». Organic Letters 10 (7): 1365-1368. PMID 18311991. doi:10.1021/ol800101v.
Burns AC, Forsyth CJ (January 2008). «Intramolecular Diels-Alder/Tsuji allylation assembly of the functionalized trans-decalin of salvinorin A». Organic Letters 10 (1): 97-100. PMID 18062692. doi:10.1021/ol7024058.
Line NJ, Burns AC, Butler SC, Casbohm J, Forsyth CJ (December 2016). «Total Synthesis of (-)-Salvinorin A». Chemistry 22 (50): 17983-17986. PMID 27758012. doi:10.1002/chem.201604853.
Brito-da-Costa AM, Dias-da-Silva D, Gomes NG, Dinis-Oliveira RJ, Madureira-Carvalho Á (February 2021). «Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects». Pharmaceuticals 14 (2): 116. PMC 7913753. PMID 33546518. doi:10.3390/ph14020116.
Hatipoglu SD, Yalcinkaya B, Akgoz M, Ozturk T, Goren AC, Topcu G (November 2017). «Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species». Phytochemical Analysis 28 (6): 541-549. PMID 28722248. doi:10.1002/pca.2703.

pubchem.ncbi.nlm.nih.gov

«Salvinorin A». pubchem.ncbi.nlm.nih.gov.

proquest.com

search.proquest.com

Valdés III LJ (1983). The pharmacognosy of Salvia divinorum (Epling and Jativa-M): An Investigation of Ska Maria Pastora (Mexico) (Tesis de PhD). University of Michigan. ProQuest 303280881.

sciencephoto.com

Kunkel D (2007). «Leaf glandular trichome (Salvia divinorum)». Dennis Kunkel Microscopy, Inc. Consultado el 4 de abril de 2022.